Ciro Canetta
Overview
Explore the profile of Ciro Canetta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diagnostic Algorithm Using Multimodal Imaging for the Differential Diagnosis of Intra-Cardiac Masses
Sozzi F, Gnan E, Pandolfi A, Iacuzio L, Kim J, Canetta C, et al.
J Clin Med
. 2025 Jan;
14(2).
PMID: 39860514
Cardiac masses are complex clinical conditions that frequently pose diagnostic challenges in cardiology practice. These masses can form within heart chambers or near the pericardium and are generally categorized as...
2.
Ceriani E, Milani O, Donadoni M, Benetti A, Berra S, Canetta C, et al.
Intern Emerg Med
. 2024 Dec;
PMID: 39656348
The ongoing demographic, epidemiological and social changes are dramatically raising the clinical and care complexity of patients admitted to internal medicine (IM) departments. Collecting evidence for a better characterization of...
3.
Alteri C, Teri A, Liporace M, Muscatello A, Terranova L, Schianca M, et al.
Ann Clin Microbiol Antimicrob
. 2024 Nov;
23(1):104.
PMID: 39614286
Background: During prolonged FDC therapy, the emergence of FDC non-susceptibility in CRAB has been reported. Here, we report a transmission cluster of FDC-non-susceptible CRAB in four patients, all naïve to...
4.
Canuti M, Fassio F, Genovese C, Giacomelli A, Ridolfo A, Asperges E, et al.
Infect Dis Ther
. 2024 Oct;
13(11):2471-2474.
PMID: 39352650
No abstract available.
5.
Sozzi F, Gnan E, Faggiano A, Giangiacomi F, Iacuzio L, Canetta C, et al.
Front Cardiovasc Med
. 2024 Aug;
11:1367467.
PMID: 39135615
Introduction: Myocardial calcifications (MC) represent a relatively rare pathological process, which may accompany different cardiovascular conditions and can be broadly categorized as dystrophic or metastatic. Myocardial infarction (MI) has been...
6.
Sozzi F, Iacuzio L, Gnan E, Levy F, Eker A, Canetta C, et al.
Kardiol Pol
. 2024 Jul;
82(7-8):806-807.
PMID: 38973438
No abstract available.
7.
Biscarini S, Mangioni D, Bobbio C, Mela L, Alagna L, Baldelli S, et al.
BMC Infect Dis
. 2024 Jun;
24(1):650.
PMID: 38943088
Background: Intravenous fosfomycin (IVFOF) is gaining interest in severe infections. Its use may be limited by adverse events (AEs). Little experience exists on IVFOF therapeutic drug monitoring (TDM) in real-life...
8.
Canetta C, Accordino S, La Boria E, Arosio G, Cacco S, Formagnana P, et al.
Eur J Intern Med
. 2024 May;
127:105-111.
PMID: 38735801
Background: the burden of acute complex patients, increasingly older and poli-pathological, accessing to Emergency Departments (ED) leads up hospital overcrowding and the outlying phenomenon. These issues highlight the need for...
9.
Colaneri M, Genovese C, Fassio F, Canuti M, Giacomelli A, Ridolfo A, et al.
Infect Dis Ther
. 2024 Apr;
13(5):1147-1157.
PMID: 38643431
Introduction: Recent studies have highlighted the prognostic value of easily accessible inflammatory markers, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for predicting severe outcomes in patients affected by Coronavirus disease...
10.
Canuti M, Monti M, Bobbio C, Muscatello A, Muheberimana T, Baldi S, et al.
Front Med (Lausanne)
. 2023 Sep;
10:1260950.
PMID: 37746083
Specific immune suppression types have been associated with a greater risk of severe COVID-19 disease and death. We analyzed data from patients >17 years that were hospitalized for COVID-19 at...